These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Global identification of O-GlcNAc-modified proteins. Nandi A, Sprung R, Barma DK, Zhao Y, Kim SC, Falck JR, Zhao Y. Anal Chem; 2006 Jan 15; 78(2):452-8. PubMed ID: 16408927 [Abstract] [Full Text] [Related]
12. Nucleocytoplasmic glycosylation, O-GlcNAc: identification and site mapping. Zachara NE, Cheung WD, Hart GW. Methods Mol Biol; 2004 Jun 03; 284():175-94. PubMed ID: 15173616 [Abstract] [Full Text] [Related]
13. Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of alpha4 phosphoprotein and Sp1 in rat lymphoma cells. Dauphinee SM, Ma M, Too CK. J Cell Biochem; 2005 Oct 15; 96(3):579-88. PubMed ID: 16052526 [Abstract] [Full Text] [Related]
17. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation. Whelan SA, Hart GW. Circ Res; 2003 Nov 28; 93(11):1047-58. PubMed ID: 14645135 [Abstract] [Full Text] [Related]
18. O-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1. Lim K, Chang HI. FEBS Lett; 2009 Feb 04; 583(3):512-20. PubMed ID: 19070619 [Abstract] [Full Text] [Related]